SUMF2 interacts with interleukin-13 and inhibits interleukin-13 secretion in bronchial smooth muscle cells

Journal of Cellular Biochemistry

Volumn 108, Issue 5, 2009, Pages 1076-1083

  Liang, Hongyan ^a   Li, Zhengjun ^a   Xue, Li ^a   Jiang, Xiaofeng ^a   Liu, Fang ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Bronchial smooth muscle cells; Glycosylation; Interleukin 13; Lymphocytes; Secretion; Sulfatase modifying factor 2

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; MESSENGER RNA; SMALL INTERFERING RNA; SULFATASE; SULFATASE MODIFYING FACTOR 2; TUNICAMYCIN; UNCLASSIFIED DRUG;

ARTICLE; BRONCHUS MUSCLE; CONTROLLED STUDY; CYTOKINE RELEASE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LYMPHOCYTE; MOLECULAR WEIGHT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN PROTEIN INTERACTION; SCREENING; SMOOTH MUSCLE FIBER;

BRONCHI; CELLS, CULTURED; GENE KNOCKDOWN TECHNIQUES; GLYCOSYLATION; HUMANS; INFLAMMATION; INTERLEUKIN-13; LYMPHOCYTES; MYOCYTES, SMOOTH MUSCLE; PROTEIN BINDING; SULFATASES;

EID: 72449144996     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22336     Document Type: Article

References (25)

1. Allahverdian S, Harada N, Singhera GK, Knight DA, Dorscheid DR. 2008. Secretion of IL-13 by airway epithelial cells enhances epithelial repair via HB-EGF. Am J Respir Cell Mol Biol 38:153-160. (Pubitemid 351162836)
2. Blease K. 2008. Therapeutics targeting IL-13 for the treatment of pulmonary inflammation and airway remodeling. Curr Opin Investig Drugs 9:1180-1184.
3. Booth B, Sandifer T, Martin EL, Martin LD. 2007. IL-13-induced proliferation of airway epithelial cells: Mediation by intracellular growth factor mobilization and ADAM17. Respir Res 8:51.
4. Burd P, Thompson WC, Max EE, Mills FC. 1995. Activated mast cells produce interleukin 13. J Exp Med 181:1373-1380.
5. Chan V, Burgess JK, Ratoff JC, O'connor BJ, Greenough A, Lee TH, Hirst SJ. 2006. Extracellular matrix regulates enhanced eotaxin expression in asthmatic airway smooth muscle cells. Am J Respir Crit Care Med 174:379-385.
6. Chiba Y, Nakazawa S, Todoroki M, Shinozaki K, Sakai H, Misawa M. 2009. Interleukin-13 augments bronchial smooth muscle contractility with an up-regulation of RhoA protein. Am J Respir Cell Mol Biol 40:159-167.
7. Farghaly H, Blagbrough IS, Medina-Tato DA, Watson ML. 2008. Interleukin 13 increases contractility of murine tracheal smooth muscle by a phosphoinositide 3-kinase p110delta-dependent mechanism. Mol Pharmacol 73:1530-1537. (Pubitemid 351574842)
8. Fulkerson P, Fischetti CA, Hassman LM, Nikolaidis NM, Rothenberg ME. 2006. Persistent effects induced by IL-13 in the lung. Am J Respir Cell Mol Biol 35:337-346. (Pubitemid 44353402)
9. Gande S, Mariappan M, Schmidt B, Pringle TH, von Figura K, Dierks T. 2008. Paralog of the formylglycine-generating enzyme-retention in the endoplasmic reticulum by canonical and noncanonical signals. FEBS J 275:1118-1130. (Pubitemid 351342208)
10. Hunninghake G, Soto-Quirós ME, Avila L, Su J, Murphy A, Demeo DL, Ly NP, Liang C, Sylvia JS, Klanderman BJ, Lange C, Raby BA, Silverman EK, Celedón JC. 2007. Polymorphisms in IL13, total IgE, eosinophilia, and asthma exacerbations in childhood. J Allergy Clin Immunol 120:84-90. (Pubitemid 46990504)
11. Izuhara K, Arima K, Kanaji S, Ohta S, Kanaji T. 2006. IL-13: A promising therapeutic target for bronchial asthma. Curr Med Chem 13:2291-2298. (Pubitemid 44184653)
12. Kasaian M, Miller DK. 2008. IL-13 as a therapeutic target for respiratory disease. Biochem Pharmacol 76:147-155.
13. Landgrebe J, Dierks T, Schmidt B, von Figura K. 2003. The human SUMF1 gene, required for posttranslational sulfatase modification, defines a new gene family which is conserved from pro- to eukaryotes. Gene 316:47-56. (Pubitemid 37249352)
14. Mariappan M, Preusser-Kunze A, Balleininger M, Eiselt N, Schmidt B, Gande SL, Wenzel D, Dierks T, von Figura K. 2005. Expression, localization, structural, and functional characterization of pFGE, the paralog of the C alpha-formylglycine-generating enzyme. J Biol Chem 280:15173-15179. (Pubitemid 40562872)
15. McKenzie A, Culpepper JA, de Waal Malefyt R, Brière F, Punnonen J, Aversa G, Sato A, Dang W, Cocks BG, Menon S, Vrist J, Banchereaut J, Zurawski G. 1993. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci USA 90:3735-3739.
16. Moynihan B, Tolloczko B, El Bassam S, Ferraro P, Michoud MC, Martin JG, Laberge S. 2008. IFN-gamma, IL-4 and IL-13 modulate responsiveness of human airway smooth muscle cells to IL-13. Respir Res 30:84.
17. Saha S, Berry MA, Parker D, Siddiqui S, Morgan A, May R, Monk P, Bradding P, Wardlaw AJ, Pavord ID, Brightling CE. 2008. Increased sputum and bronchial biopsy IL-13 expression in severe asthma. J Allergy Clin Immunol 121(3): 685-691. (Pubitemid 351323866)
18. Tesfaigzi Y. 2008. Regulation of mucous cell metaplasia in bronchial asthma. Curr Mol Med 8:408-415.
19. Tliba O, Panettieri RA Jr. 2009. Noncontractile functions of airway smooth muscle cells in asthma. Annu Rev Physiol 71:509-535.
20. Venkayya R, Lam M, Willkom M. 2002. The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. Am J Respir Cell Mol Biol 26:202-208. (Pubitemid 34107874)
21. Wills-Karp M. 2004. Interleukin-13 in asthma pathogenesis. Immunol Rev 202:175-190.
22. Xiang J, Rir-Sim-Ah J, Tesfaigzi Y. 2008. IL-9 and IL-13 induce mucous cell metaplasia that is reduced by IFN-gamma in a Bax-mediated pathway. Am J Respir Cell Mol Biol 38:310-317. (Pubitemid 351567700)
23. Yao X, He HY, Yang Y, Dai SL, Sun PL, Yin KS, Huang M. 2008. Inhibition of interleukin-13 gene expression in T cells through GATA-3 pathway by arsenic trioxide. Chin Med J (Engl) 121:2346-2349.
24. Zhu J, Yamane H, Cote-Sierra J, Guo L, Paul WE. 2006. GATA-3 promotes Th2 responses through three different mechanisms: Induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors. Cell Res 16:3-10. (Pubitemid 43129303)
25. Zito E, Fraldi A, Pepe S, Annunziata I, Kobinger G, Di Natale P, Ballabio A, Cosma MP. 2005. Sulphatase activities are regulated by the interaction of sulphatase-modifying factor 1 with SUMF2. EMBO Rep 6:655-660. (Pubitemid 41122434)